Xinfeng Wang1,2, Wai San Cheang3, Haixia Yang1,4, Lei Xiao1, Baochang Lai1, Meiqian Zhang1, Jiahua Ni1, Zhenyu Luo1, Zihui Zhang1, Yu Huang3, Nanping Wang1,5. 1. Cardiovascular Research Center, Xi'an Jiaotong University, Xi'an, China. 2. Department of Physiology and Pathophysiology, School of Medicine, Xi'an Jiaotong University, Xi'an, China. 3. Institute of Vascular Medicine, School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, China. 4. School of Public Health, Xi'an Jiaotong University, Xi'an, China. 5. Institute of Cardiovascular Sciences, Peking University Health Science Center, Beijing, China.
Abstract
BACKGROUND AND PURPOSE: Nuciferine, a constituent of lotus leaf, is an aromatic ring-containing alkaloid, with antioxidative properties. We hypothesize nuciferine might affect vascular reactivity. This study aimed at determining the effects of nuciferine on vasomotor tone and the underlying mechanism EXPERIMENTAL APPROACH: Nuciferine-induced relaxations in rings of rat main mesenteric arteries were measured by wire myographs. Endothelial NOS (eNOS) was determined by immunoblotting. Intracellular NO production in HUVECs and Ca(2+) level in both HUVECs and vascular smooth muscle cells (VSMCs) from rat mesenteric arteries were assessed by fluorescence imaging. KEY RESULTS: Nuciferine induced relaxations in arterial segments pre-contracted by KCl or phenylephrine. Nuciferine-elicited arterial relaxations were reduced by removal of endothelium or by pretreatment with the eNOS inhibitor L-NAME or the NO-sensitive guanylyl cyclase inhibitor ODQ. In HUVECs, the phosphorylation of eNOS at Ser(1177) and increase in cytosolic NO level induced by nuciferine were mediated by extracellular Ca(2+) influx. Under endothelium-free conditions, nuciferine attenuated CaCl2-induced contraction in Ca(2+)-free depolarizing medium. In the absence of extracellular calcium, nuciferine relieved the vasoconstriction induced by phenylephrine and the addition of CaCl2. Nuciferine also suppressed Ca(2+) influx in Ca(2+)-free K(+)-containing solution in VSMCs. CONCLUSIONS AND IMPLICATIONS: Nuciferine has a vasorelaxant effect via both endothelium-dependent and -independent mechanisms. These results suggest that nuciferine may have a therapeutic effect on vascular diseases associated with aberrant vasoconstriction.
BACKGROUND AND PURPOSE:Nuciferine, a constituent of lotus leaf, is an aromatic ring-containing alkaloid, with antioxidative properties. We hypothesize nuciferine might affect vascular reactivity. This study aimed at determining the effects of nuciferine on vasomotor tone and the underlying mechanism EXPERIMENTAL APPROACH: Nuciferine-induced relaxations in rings of rat main mesenteric arteries were measured by wire myographs. Endothelial NOS (eNOS) was determined by immunoblotting. Intracellular NO production in HUVECs and Ca(2+) level in both HUVECs and vascular smooth muscle cells (VSMCs) from rat mesenteric arteries were assessed by fluorescence imaging. KEY RESULTS:Nuciferine induced relaxations in arterial segments pre-contracted by KCl or phenylephrine. Nuciferine-elicited arterial relaxations were reduced by removal of endothelium or by pretreatment with the eNOS inhibitor L-NAME or the NO-sensitive guanylyl cyclase inhibitor ODQ. In HUVECs, the phosphorylation of eNOS at Ser(1177) and increase in cytosolic NO level induced by nuciferine were mediated by extracellular Ca(2+) influx. Under endothelium-free conditions, nuciferine attenuated CaCl2-induced contraction in Ca(2+)-free depolarizing medium. In the absence of extracellular calcium, nuciferine relieved the vasoconstriction induced by phenylephrine and the addition of CaCl2. Nuciferine also suppressed Ca(2+) influx in Ca(2+)-free K(+)-containing solution in VSMCs. CONCLUSIONS AND IMPLICATIONS: Nuciferine has a vasorelaxant effect via both endothelium-dependent and -independent mechanisms. These results suggest that nuciferine may have a therapeutic effect on vascular diseases associated with aberrant vasoconstriction.
Authors: Hanspeter Brunner; John R Cockcroft; John Deanfield; Ann Donald; Ele Ferrannini; Julian Halcox; Wolfgang Kiowski; Thomas F Lüscher; Giuseppe Mancia; Andrea Natali; James J Oliver; Achille C Pessina; Damiano Rizzoni; Gian Paolo Rossi; Antonio Salvetti; Lukas E Spieker; Stefano Taddei; David J Webb Journal: J Hypertens Date: 2005-02 Impact factor: 4.844
Authors: Yana J Anfinogenova; Mikhail B Baskakov; Igor V Kovalev; Alexander A Kilin; Nickolai O Dulin; Sergei N Orlov Journal: Pflugers Arch Date: 2004-10 Impact factor: 3.657
Authors: Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar Journal: Br J Pharmacol Date: 2013-12 Impact factor: 8.739
Authors: Justin L Poklis; Haley A Mulder; Matthew S Halquist; Carl E Wolf; Alphonse Poklis; Michelle R Peace Journal: J Psychoactive Drugs Date: 2017-03-07